 |
PDBsum entry 3r21
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3r21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Design, synthesis, and biological evaluation of pyrazolopyridine- sulfonamides as potent multiple-mitotic kinase (mmk) inhibitors (part i)
|
|
Structure:
|
 |
Serine/threonine-protein kinase 6. Chain: a. Fragment: unp residues 126-391. Synonym: aurora kinase a, aurora/ipl1-related kinase 1, ark-1, aurora-related kinase 1, hark1, breast tumor-amplified kinase, serine/threonine-protein kinase 15, serine/threonine-protein kinase aurora-a. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: aik, ark1, aura, aurka, btak, stk15, stk6. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9.
|
|
Resolution:
|
 |
|
2.90Å
|
R-factor:
|
0.260
|
R-free:
|
0.305
|
|
|
Authors:
|
 |
L.Zhang,J.Fan,J.-H.Chong,A.Cesena,B.Tam,C.Gilson,C.Boykin,D.Wang, D.Marcotte,J.-Y.Le Brazidec,D.Aivazian,J.Piao,K.Lundgren,K.Hong, K.Vu,K.Nguyen
|
|
Key ref:
|
 |
L.Zhang
et al.
(2011).
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).
Bioorg Med Chem Lett,
21,
5633-5637.
PubMed id:
|
 |
|
Date:
|
 |
|
11-Mar-11
|
Release date:
|
10-Aug-11
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O14965
(AURKA_HUMAN) -
Aurora kinase A from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
403 a.a.
254 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Bioorg Med Chem Lett
21:5633-5637
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).
|
|
L.Zhang,
J.Fan,
J.H.Chong,
A.Cesena,
B.Y.Tam,
C.Gilson,
C.Boykin,
D.Wang,
D.Aivazian,
D.Marcotte,
G.Xiao,
J.Y.Le Brazidec,
J.Piao,
K.Lundgren,
K.Hong,
K.Vu,
K.Nguyen,
L.S.Gan,
L.Silvian,
L.Ling,
M.Teng,
M.Reff,
N.Takeda,
N.Timple,
Q.Wang,
R.Morena,
S.Khan,
S.Zhao,
T.Li,
W.C.Lee,
A.G.Taveras,
J.Chao.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |